1. Acute changes in plasma glucose increases left ventricular systolic function in insulin‐treated patients with type 2 diabetes and controls. Issue 6 (22nd March 2022) Authors: Andersen, Andreas; Jørgensen, Peter G.; Bagger, Jonatan I.; Baldassarre, Maria P. A.; Christensen, Mikkel B.; Pedersen‐Bjergaard, Ulrik; Lindhardt, Tommi B.; Gislason, Gunnar; Knop, Filip K.; Vilsbøll, Tina Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 6(2022) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Issue 9 (20th June 2022) Authors: Stensen, Signe; Krogh, Liva L.; Sparre‐Ulrich, Alexander H.; Dela, Flemming; Hartmann, Bolette; Vilsbøll, Tina; Holst, Jens J.; Rosenkilde, Mette M.; Christensen, Mikkel B.; Gasbjerg, Lærke S.; Knop, Filip K. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 9(2022) Page Start: 1882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weight. Issue 1 (23rd February 2021) Authors: Theilade, Simone; Christensen, Mikkel B.; Vilsbøll, Tina; Knop, Filip K. Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 1(2021)Supplement Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cardiovascular biomarkers in clinical studies of type 2 diabetes. Issue 6 (5th March 2018) Authors: Baldassarre, Maria P. A.; Andersen, Andreas; Consoli, Agostino; Knop, Filip K.; Vilsbøll, Tina Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 6(2018) Page Start: 1350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cardiovascular safety and benefits of GLP-1 receptor agonists. Issue 3 (4th March 2017) Authors: Dalsgaard, Niels B.; Brønden, Andreas; Vilsbøll, Tina; Knop, Filip K. Journal: Expert opinion on drug safety Issue: Volume 16:Issue 3(2017:Mar.) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs. (2nd December 2018) Authors: Rehfeld, Jens F.; Knop, Filip K.; Asmar, Ali; Madsbad, Sten; Holst, Jens J.; Asmar, Meena Journal: Scandinavian journal of gastroenterology Issue: Volume 53:Number 12(2018) Page Start: 1429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical characteristics and glucose‐lowering drug utilization among patients initiating liraglutide in Denmark: a routine clinical care prescription study. Issue 8 (25th April 2019) Authors: Knudsen, Jakob S.; Thomsen, Reimar W.; Pottegård, Anton; Knop, Filip K.; Sørensen, Henrik T. Journal: Journal of diabetes Issue: Volume 11:Issue 8(2019) Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium–Glucose Cotransporter 2 Inhibitor Treatment. Issue 2 (11th September 2015) Authors: Storgaard, Heidi; Bagger, Jonatan I.; Knop, Filip K.; Vilsbøll, Tina; Rungby, Jørgen Journal: Basic & clinical pharmacology & toxicology Issue: Volume 118:Issue 2(2016) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of exercise combined with glucagon‐like peptide‐1 receptor agonist treatment on cardiac function: A randomized double‐blind placebo‐controlled clinical trial. Issue 7 (20th March 2017) Authors: Jørgensen, Peter G.; Jensen, Magnus T.; Mensberg, Pernille; Storgaard, Heidi; Nyby, Signe; Jensen, Jan S.; Knop, Filip K.; Vilsbøll, Tina Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 7(2017) Page Start: 1040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial. Issue 2 (14th November 2016) Authors: Ishøy, Pelle L.; Knop, Filip K.; Broberg, Brian V.; Bak, Nikolaj; Andersen, Ulrik B.; Jørgensen, Niklas R.; Holst, Jens J.; Glenthøj, Birte Y.; Ebdrup, Bjørn H. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 2(2017) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗